| 000 | 01562 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516070624.0 | ||
| 264 | 0 | _c20120612 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1665-2681 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMata Marín, José Antonio | |
| 245 | 0 | 0 |
_aPrevalence and resistance pattern of genotype G and H in chronic hepatitis B and HIV co-infected patients in Mexico. _h[electronic resource] |
| 260 |
_bAnnals of hepatology _c |
||
| 300 |
_a47-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV _xgenetics |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLamivudine _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMexico _xepidemiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aArroyo Anduiza, Carla Ileana | |
| 700 | 1 | _aCalderón, Gloria María | |
| 700 | 1 | _aCazares Rodríguez, Sergio | |
| 700 | 1 | _aFuentes Allen, José Luis | |
| 700 | 1 | _aArias Flores, Rafael | |
| 700 | 1 | _aGaytán Martínez, Jesús | |
| 773 | 0 |
_tAnnals of hepatology _gvol. 11 _gno. 1 _gp. 47-51 |
|
| 999 |
_c21388992 _d21388992 |
||